NEO1 and NEO-EXT studies: pharmacodynamic and exploratory biomarker assessments following repeat avalglucosidase alfa dosing for up to 4.5 years in patients with late-onset Pompe disease

MUSCLE & NERVE(2019)

引用 23|浏览19
暂无评分
关键词
pharmacodynamic/exploratory biomarker,disease,neo-ext,late-onset
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要